| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0197-4580(00)00253-0 |
| P698 | PubMed publication ID | 11378244 |
| P50 | author | Gérard Siest | Q57421058 |
| P2093 | author name string | J Fujii | |
| N Taniguchi | |||
| I Laffont | |||
| V V Shuvaev | |||
| J M Serot | |||
| P2860 | cites work | Advanced glycation endproducts in ageing and Alzheimer's disease | Q73138940 |
| Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts | Q77164116 | ||
| Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
| “Mini-mental state” | Q25938989 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Role of the Maillard reaction in diabetes mellitus and diseases of aging | Q30425246 | ||
| Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia | Q33511509 | ||
| Transthyretin (prealbumin) in health and disease: nutritional implications | Q34324684 | ||
| Advanced glycation end products contribute to amyloidosis in Alzheimer disease | Q35285651 | ||
| Advanced Maillard reaction end products are associated with Alzheimer disease pathology | Q35527031 | ||
| Radical AGEing in Alzheimer's disease | Q40542915 | ||
| Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. | Q40626983 | ||
| Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo | Q40903084 | ||
| Aging, metabolism, and Alzheimer disease: review and hypotheses | Q41319187 | ||
| Oxidative stress caused by glycation of Cu,Zn-superoxide dismutase and its effects on intracellular components | Q41357659 | ||
| Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta | Q46256650 | ||
| An immunochemical study on tau glycation in paired helical filaments | Q48188316 | ||
| Plasma protein glycation in Alzheimer's disease | Q48231681 | ||
| White matter changes with normal aging. | Q48480340 | ||
| Altered choroid plexus basement membrane and epithelium in late-onset Alzheimer's disease: an ultrastructural study. | Q48607367 | ||
| Advanced glycation modification of Rosenthal fibers in patients with Alexander disease | Q48638245 | ||
| Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease | Q48888308 | ||
| The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man. | Q48930813 | ||
| Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease. | Q53213016 | ||
| Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. | Q53233059 | ||
| Increased lipoprotein oxidation in Alzheimer's disease. | Q53233479 | ||
| Correlation of isotopic cisternographic patterns in multiple sclerosis with CSF IgG values. | Q54196853 | ||
| Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site | Q57996115 | ||
| Cerebrospinal fluid production is reduced in healthy aging | Q68730824 | ||
| Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG | Q71715975 | ||
| Inhibitory effect of nonenzymatic glycation on ubiquitination and ubiquitin-mediated degradation of lysozyme | Q72968433 | ||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| cerebrospinal fluid | Q54196 | ||
| P304 | page(s) | 397-402 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | Increased protein glycation in cerebrospinal fluid of Alzheimer's disease | |
| P478 | volume | 22 |
| Q37788385 | 1-Amino-1-deoxy-D-fructose ("fructosamine") and its derivatives. |
| Q41325603 | A Novel Plasma Based Biomarker of Alzheimer's Disease |
| Q37097143 | A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease |
| Q37404327 | A review of glycated albumin as an intermediate glycation index for controlling diabetes |
| Q31021996 | Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma |
| Q35708114 | Alzheimer's disease: the two-hit hypothesis |
| Q47947254 | An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus |
| Q34079319 | Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. |
| Q37548988 | Carnosine and its possible roles in nutrition and health |
| Q46032058 | Carnosine, diabetes and Alzheimer's disease. |
| Q38153679 | Cerebrospinal fluid secretion by the choroid plexus |
| Q48773260 | Choroid plexus and ageing in rats: a morphometric and ultrastructural study |
| Q33372798 | Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. |
| Q35670859 | Dietary advanced glycation end products and aging |
| Q50578085 | Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products. |
| Q38288068 | Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. |
| Q41764565 | Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays |
| Q46456572 | Effect of non-enzymatic glycation on aluminium-induced lipid peroxidation of human high density lipoproteins (HDL). |
| Q48715748 | Effects of transthyretin on thyroxine and β-amyloid removal from cerebrospinal fluid in mice. |
| Q34068791 | Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine. |
| Q58055764 | Glycated albumin. A glycemic control index to be reevaluated |
| Q27012452 | Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker |
| Q38762228 | Glycation in Parkinson's disease and Alzheimer's disease |
| Q48664693 | Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease. |
| Q43058506 | Glycemia and levels of cerebrospinal fluid amyloid and tau in patients attending a memory clinic |
| Q35993403 | Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells |
| Q48097957 | High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease |
| Q39368611 | Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention. |
| Q34291417 | Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease |
| Q84816901 | Inhibition of advanced glycation end-product formation on eye lens protein by rutin |
| Q39042377 | Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease |
| Q59808617 | Insulin Resistance in Alzheimer's Disease |
| Q35164047 | Involvement of Maillard reactions in Alzheimer disease |
| Q48170304 | Long-term physical activity leads to a significant increase in serum sRAGE levels: a sign of decreased AGE-mediated inflammation due to physical activity? |
| Q48178370 | Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinases |
| Q37163564 | Multiplicity of cerebrospinal fluid functions: New challenges in health and disease |
| Q37903708 | Naturally occurring inhibitors against the formation of advanced glycation end-products |
| Q58737028 | Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches |
| Q38151611 | Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies. |
| Q46663366 | Oxidative Stress Mediated Cytotoxicity of Glycated Albumin: Comparative Analysis of Glycation by Glucose Metabolites |
| Q36203957 | Oxidative stress and neurodegeneration |
| Q44260190 | Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia |
| Q46262747 | Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications |
| Q92776053 | Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-induced Memory Impairment in Mice |
| Q45233001 | Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment |
| Q33898968 | Reduced CSF turnover and decreased ventricular Aβ42 levels are related |
| Q39064330 | Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7). |
| Q27004644 | Role of methylglyoxal in Alzheimer's disease |
| Q35626858 | Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals |
| Q28511830 | Severe neurologic impairment in mice with targeted disruption of the electrogenic sodium bicarbonate cotransporter NBCe2 (Slc4a5 gene) |
| Q44969807 | Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway |
| Q35619553 | The association of diabetes and dementia and possible implications for nondiabetic populations |
| Q33600053 | The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease |
| Q38074422 | The role of vitamin D in Alzheimer's disease: possible genetic and cell signaling mechanisms |
| Q36337525 | Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease |
| Q36521008 | Would carnosine or a carnivorous diet help suppress aging and associated pathologies? |
Search more.